RxDoctor Payments Data

Joseph Cook, DO

Family Medicine · Surprise, AZNPI 1760639892

Payments from drug & device makers

$2,563in general payments, 2019–2025

Across 187 payments — averaging $13.71 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.

  • Novo Nordisk$494
  • Pfizer$324
  • GSK$289
  • AstraZeneca$180
  • AbbVie$167
  • Amarin Pharma, Inc.$144
  • plus $964 from 21 others

What the payments were for

  • Food & beverage$2,52899%
  • Education$351%

Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.

General payments by program year

19
20
23
24
25

Who reported the general payments

Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.

How this compares

$2,563 in reported general payments places this provider in the 80th percentile of 2,099 family medicine providers in Arizona.

See all family medicine providers in Arizona

Medicare billing

Part B allowed, 2024
$205,267
Medicare patients
362
Services billed
2,789

What this is not: this is the amount Original Medicare Part B allowed for services this provider billed in 2024. It is not their income. It excludes Medicare Advantage — now more than half of all Medicare enrollment — along with Medicaid and all commercial insurance, and it is gross practice revenue before staff, rent, supplies and malpractice premiums. CMS also suppresses any figure covering ten or fewer patients, so low-volume providers appear smaller than they are.

Most prescribed under Part D

DrugClaimsCost to plans & patients
OzempicSemaglutide74$85,982
EliquisApixaban42$61,233
TradjentaLinagliptin37$56,342
JardianceEmpagliflozin25$36,630
Trelegy ElliptaFluticasone/Umeclidin/Vilanter25$36,404
TrulicityDulaglutide28$36,055
MounjaroTirzepatide11$24,320
MyrbetriqMirabegron14$14,223
Lantus SolostarInsulin Glargine,hum.Rec.Anlog30$8,018
Humalog Kwikpen U-100Insulin Lispro15$7,286
Varenicline Tartrate16$5,256
Rosuvastatin Calcium292$2,977
Losartan Potassium266$2,499
Testosterone Cypionate35$2,016
Metoprolol Succinate160$1,872

Paid to pharmacies, not to this prescriber.

Companies that both paid and supply prescribed drugs

These companies both reported payments to this provider and make drugs the provider prescribed under Medicare Part D in 2024. For most specialties this overlap is expected — a cardiologist who is paid by a cardiology drugmaker also treats heart disease. It is shown so the reader can see it, not because it implies anything on its own.

CompanyPaid to this providerPart D cost of their drugs
Boehringer IngelheimTradjenta, Jardiance$28$92,97262 claims
Novo NordiskOzempic$494$85,98274 claims
PfizerEliquis$324$61,23342 claims
Lilly USA, LLCTrulicity, Mounjaro$115$60,37539 claims
GSKTrelegy Ellipta$289$36,40425 claims
Astellas Pharma US IncMyrbetriq$32$14,22314 claims
AbbVieSynthroid$167$1,64427 claims

Reading this fairly. The Part D column is what drug plans and patients paid pharmacies — this provider received none of it, and it reflects how many patients they treat and what those drugs cost. Against peers, this provider's reported payments sit in the 80th percentile of 2,099 family medicine providers in Arizona.

Other family medicine in Surprise

See the full list for Arizona

Where these figures come from

Is this you, or does something look wrong? →